Niall O'Donnell

Director, Mirum Pharmaceuticals.

Companies

OnKure Therapeutics, Inc.Board member Apr 8, 2021 to Jun 8, 2023¹
SPRUCE BIOSCIENCES, INC.Board member Oct 8, 2020 to May 26, 2023²
Mirum PharmaceuticalsBoard member Jul 17, 2019 to Nov 15, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Mirum Pharmaceuticals MIRM1,621,118 shares⁴$133.3M at $82.23Nov 15, 2022
SPRUCE BIOSCIENCES, INC. SPRB1,326,305 shares⁵$53.7M at $40.47Feb 16, 2023
OnKure Therapeutics, Inc. OKUR2,188,713 shares⁶$4.7M at $2.15May 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

May 8, 2023Bought 125,000 shares at $8.00 of OnKure Therapeutics, Inc.⁶
Feb 16, 2023Bought 630,400 shares at $3.17 of SPRUCE BIOSCIENCES, INC.⁵
Nov 15, 2022Sold 93,770 shares at $19.69 of Mirum Pharmaceuticals⁴
Nov 14, 2022Sold 32,109 shares at $19.60 of Mirum Pharmaceuticals⁴
Nov 11, 2022Sold 174,121 shares at $19.99 of Mirum Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROnKure Therapeutics, Inc., Board member
2
SEC EDGARSPRUCE BIOSCIENCES, INC., Board member
3
SEC EDGARMirum Pharmaceuticals, Board member
4
SEC EDGARMirum Pharmaceuticals shares after the filing of Nov 15, 2022
5
SEC EDGARSPRUCE BIOSCIENCES, INC. shares after the filing of Feb 16, 2023
6
SEC EDGAROnKure Therapeutics, Inc. shares after the filing of May 8, 2023